Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 5293-5304 of 5640

PR Newswire associated0

Yuyu Pharma to attend 'CPHI Worldwide 2023'

PR Newswire associated0

SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products

ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023

The new UVDI-GO UV LED Surface Sanitizer inactivates C. difficile spores in only 20 seconds from 4" (10.2 cm) away (Photo: Business Wire)

New UVDI-GO™ UV LED Surface Sanitizer Inactivates High-Risk Microorganisms in 20 Seconds or Less

(Photo: Business Wire)

BioMed Realty and Babraham Research Campus Announce Full Letting of Newest Life Science Development on Campus Ahead of Scheduled Completion

Bringing together, all stakeholders involved in research on physical, chemical, and biological realms, biomaterials, and tissue engineering systems to develop novel solutions in regenerative medicine has been the major goal and accomplishment of NCRM NICHE, in the past 18 years. Winners and finalists of Fujio Cup Quiz (FCQ), the “FCQ Elites” are qualified to nominate the candidates for the Edogawa NICHE Prize. The inaugural prize in 2018 was awarded to Prof. James E. Till for discovery of stem cells, jointly with Prof. Ernest McCulloch. 2019 prize was awarded to Dr. Steven A. Rosenberg, for his pioneering work in adoptive immunotherapies and in 2020 to Dr. John Craig Venter for his research in synthetic biology and the human genome. NCRM NICHE team is progressing in research on implications of microgravity, synthetic chemical concoctions, and biological response modifiers, on cellular senescence and immune modulation to develop solutions, especially for rare diseases and unmet needs. (Graphic: Business Wire)

Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

PR Newswire associated0

Aculys Pharma delivers positive Phase 3 clinical study interim analysis result of a diazepam nasal spray: an antiepileptic drug for the treatment of epileptic seizures

Business Wire associated0

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries

Business Wire logo

Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire

Business Wire logo

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas

Oneview Healthcare, Enterprise Ireland, and Baxter at the Baxter Headquarters. (Photo: Business Wire)

Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland

PR Newswire associated0

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

  • Prev Page
  • 1
  • 2
  • …
  • 441
  • 442
  • 443
  • …
  • 469
  • 470
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us